Dr. Stefan Warmuth, PhDSVP, Head Technology and CMC at Numab Therapeutics AGSpeaker
Profile
Stefan is heading discovery and CMC activities at Numab as well as technology projects. This includes antibody discovery, protein engineering, analytics, and formulation, USP and DSP development. He is responsible for the CMC strategy and oversees the manufacturing activities of the international network of external CMOs. Stefan studied biochemistry in Tübingen and Zurich and graduated with a degree in Biochemistry from the ETH Zurich and obtained his PhD in Structural Biology and Biochemistry from the University of Zurich.
Agenda Sessions
Multispecific Antibodies Application for Inflammation and Oncology - Design and Clinical Outcomes
, 14:00View Session